Neurogenetics and Gene Therapies Across the Motor Axis

Advancements in CRISPR, antisense oligonucleotides, and whole-exome sequencing (WES) are transforming treatment strategies for disorders like SMA, ALS, and hereditary neuropathies. This session bridges central and peripheral pathologies, focusing on translational breakthroughs from bench to bedside.Delegates gain insights into regulatory approvals and clinical pipelines. Young researchers can engage with top genomic labs, while poster presenters can showcase rare mutation studies. Students will benefit from interactive tutorials on sequencing platforms and variant interpretation.

    Related Conference of Neurogenetics and Gene Therapies Across the Motor Axis

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Neurogenetics and Gene Therapies Across the Motor Axis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in